Sean Dodge
Stock Analyst at RBC Capital
(2.18)
# 1,490
Out of 4,413 analysts
135
Total ratings
35.24%
Success rate
-3%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDMO Avid Bioservices | Maintains: Outperform | $7 → $8 | $7.63 | +4.85% | 11 | Apr 30, 2024 | |
| TDOC Teladoc Health | Maintains: Outperform | $25 → $18 | $12.75 | +41.18% | 10 | Apr 26, 2024 | |
| OPRX OptimizeRx | Reiterates: Outperform | $17 | $10.20 | +66.67% | 8 | Apr 1, 2024 | |
| TBRG TruBridge | Initiates: Outperform | $13 | $7.90 | +64.56% | 1 | Mar 28, 2024 | |
| PHR Phreesia | Reiterates: Sector Perform | $23 | $20.74 | +10.90% | 12 | Mar 21, 2024 | |
| HQY HealthEquity | Maintains: Outperform | $90 → $92 | $78.91 | +16.59% | 8 | Mar 20, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $20 | $11.20 | +78.57% | 8 | Mar 11, 2024 | |
| GDRX GoodRx Holdings | Reiterates: Sector Perform | $8 | $7.10 | +12.68% | 11 | Mar 8, 2024 | |
| SRCL Stericycle | Reiterates: Outperform | $69 | $44.73 | +54.26% | 7 | Mar 7, 2024 | |
| RCM R1 RCM | Reiterates: Outperform | $19 | $12.29 | +54.60% | 10 | Mar 7, 2024 | |
| AGL agilon health | Maintains: Outperform | $11 → $8 | $5.50 | +45.45% | 4 | Feb 28, 2024 | |
| CTLT Catalent | Reiterates: Sector Perform | $64 | $55.85 | +13.70% | 15 | Feb 20, 2024 | |
| HCSG Healthcare Services Group | Maintains: Outperform | $14 → $15 | $10.62 | +41.24% | 11 | Feb 15, 2024 | |
| MDRX Veradigm | Maintains: Outperform | $22 → $11 | $7.99 | +37.67% | 3 | Jan 19, 2024 | |
| EVH Evolent Health | Maintains: Outperform | $44 → $42 | $27.74 | +51.41% | 5 | Nov 28, 2023 | |
| HCAT Health Catalyst | Maintains: Sector Perform | $13 → $8 | $6.22 | +28.62% | 7 | Oct 30, 2023 | |
| PRVA Privia Health Group | Initiates: Outperform | $36 | $18.40 | +95.65% | 1 | Mar 10, 2023 | |
| HSY Hershey | Initiates: Outperform | $33 | $193.92 | -82.98% | 1 | Sep 14, 2022 | |
| OTRK Ontrak | Maintains: Sector Perform | $66 → $12 | $0.27 | +4,279.56% | 2 | Mar 9, 2022 |
Avid Bioservices
Apr 30, 2024
Maintains: Outperform
Price Target: $7 → $8
Current: $7.63
Upside: +4.85%
Teladoc Health
Apr 26, 2024
Maintains: Outperform
Price Target: $25 → $18
Current: $12.75
Upside: +41.18%
OptimizeRx
Apr 1, 2024
Reiterates: Outperform
Price Target: $17
Current: $10.20
Upside: +66.67%
TruBridge
Mar 28, 2024
Initiates: Outperform
Price Target: $13
Current: $7.90
Upside: +64.56%
Phreesia
Mar 21, 2024
Reiterates: Sector Perform
Price Target: $23
Current: $20.74
Upside: +10.90%
HealthEquity
Mar 20, 2024
Maintains: Outperform
Price Target: $90 → $92
Current: $78.91
Upside: +16.59%
Sotera Health Company
Mar 11, 2024
Reiterates: Outperform
Price Target: $20
Current: $11.20
Upside: +78.57%
GoodRx Holdings
Mar 8, 2024
Reiterates: Sector Perform
Price Target: $8
Current: $7.10
Upside: +12.68%
Stericycle
Mar 7, 2024
Reiterates: Outperform
Price Target: $69
Current: $44.73
Upside: +54.26%
R1 RCM
Mar 7, 2024
Reiterates: Outperform
Price Target: $19
Current: $12.29
Upside: +54.60%
agilon health
Feb 28, 2024
Maintains: Outperform
Price Target: $11 → $8
Current: $5.50
Upside: +45.45%
Catalent
Feb 20, 2024
Reiterates: Sector Perform
Price Target: $64
Current: $55.85
Upside: +13.70%
Healthcare Services Group
Feb 15, 2024
Maintains: Outperform
Price Target: $14 → $15
Current: $10.62
Upside: +41.24%
Veradigm
Jan 19, 2024
Maintains: Outperform
Price Target: $22 → $11
Current: $7.99
Upside: +37.67%
Evolent Health
Nov 28, 2023
Maintains: Outperform
Price Target: $44 → $42
Current: $27.74
Upside: +51.41%
Health Catalyst
Oct 30, 2023
Maintains: Sector Perform
Price Target: $13 → $8
Current: $6.22
Upside: +28.62%
Privia Health Group
Mar 10, 2023
Initiates: Outperform
Price Target: $36
Current: $18.40
Upside: +95.65%
Hershey
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $193.92
Upside: -82.98%
Ontrak
Mar 9, 2022
Maintains: Sector Perform
Price Target: $66 → $12
Current: $0.27
Upside: +4,279.56%